HCP1904-3

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCP1904-3, covering 2023-09-22 to 2023-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients [Phase 3]